ArticleBMJ open2021

Integrating neuroimaging biomarkers into the multicentre, high-dose erythropoietin for asphyxia and encephalopathy (HEAL) trial: rationale, protocol and harmonisation.

Jessica L Wisnowski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.